Arthrex Beaming System
ARTHREX, INC. · Decision date Sep 25, 2026
What did the FDA decide?
Arthrex, Inc. received a substantially equivalent (SESE) decision for the Arthrex Beaming System under 510(k) number K262975, dated September 25, 2026, with the application received August 26, 2026. The device is classified as a bone fixation screw (21 CFR 888.3040) under product code HWC, with an orthopedic review panel. SESE denotes 510(k) clearance to market, not premarket approval.
The FDA letter describes the system as a fixation device system made of stainless steel, with beams ranging from 5 mm to 8 mm. The available excerpts do not identify a predicate device, the specific clinical indication, or the contents of any performance testing, so the basis for the equivalence determination remains unknown from this material. The record also does not state whether the submission covered a new device or a modification of a previously cleared system.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Sep 25, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262975
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- ARTHREX, INC.
- Product code
- HWC
- Decision code
- SESE
- Decision date
- Sep 25, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Screw, Fixation, Bone.
- Applicant
- Arthrex, Inc.
- Product code
- HWC
- FDA device class
- 2
FDA decision timeline
K262975 received
Application receipt date recorded by FDA.
K262975 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code HWC
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| GM Dos Reis Industria e Comercio Ltda. | 510(k) clearance | Nov 2, 2026 | FDA | |
| Nvision Biomedical Technologies | 510(k) clearance | Oct 14, 2026 | FDA | |
| OsteoCentric Technologies | 510(k) clearance | Oct 2, 2026 | FDA | |
| MEDSHAPE, INC. | 510(k) clearance | Sep 23, 2026 | FDA | |
F.A.S.T ScrewK254280 | Steps Ortho | 510(k) clearance | Sep 21, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Arthrex, Inc.
- Headquarters
- Not reported
- Brand website
- arthrex.com
- FDA applicant address
- Naples, FL
Sources and methodology
- Original FDA record: K262975
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

